HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT

Clinical trial NCT04618367 · COMPLETED

Trial details

NCT number: NCT04618367
Sponsor: Sun Yat-sen University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular Liver Neoplasms Sintilimab Portal Vein Tumor Thrombus

Start date: 2021-01-01
Primary completion: 2021-12-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.